Form 4 for SNOW Snowflake Inc.
Accepted 2026-09-22 19:17:46 ET · period of report 2026-09-18 · accession 0001628280-26-063114 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-22 19:17 | 2026-09-18+ | SNOW | Slootman Frank | Dir | M - OptEx | $8.88 | +300.0K | 121.8K | New | +$2.66M |
| DMT | 2026-09-22 19:17 | 2026-09-18+ | SNOW | Slootman Frank | Dir | S - Sale+OE | $334.49 | -300.0K | 19.0K | -94% | -$100.35M |
| DMT | 2026-09-22 19:17 | 2026-09-18+ | SNOW | Slootman Frank | Dir | M - OptEx | $0.00 | -300.0K | 4.14M | -7% | $0 |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-18 | M | A | 197,209 | $8.88 | 216,233 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 2 | Common | Common Stock | 2026-09-18 | S | D | 15,187 | $331.35 | 201,046 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F3) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $330.745 to $331.740, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 3 | Common | Common Stock | 2026-09-18 | S | D | 23,507 | $332.19 | 177,539 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F4) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $331.760 to $332.750, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 4 | Common | Common Stock | 2026-09-18 | S | D | 79,366 | $333.27 | 98,173 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F5) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $332.770 to $333.760, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 5 | Common | Common Stock | 2026-09-18 | S | D | 42,009 | $334.24 | 56,164 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F6) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $333.780 to $334.775, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 6 | Common | Common Stock | 2026-09-18 | S | D | 2,841 | $335.23 | 53,323 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F7) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $334.785 to $335.770, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 7 | Common | Common Stock | 2026-09-18 | S | D | 4,097 | $336.11 | 49,226 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F8) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $335.800 to $336.480, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 8 | Common | Common Stock | 2026-09-18 | S | D | 102 | $337.05 | 49,124 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 9 | Common | Common Stock | 2026-09-18 | S | D | 30,100 | $338.61 | 19,024 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F9) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $338.250 to $338.610, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 10 | Common | Common Stock | 2026-09-21 | M | A | 102,791 | $8.88 | 121,815 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 11 | Common | Common Stock | 2026-09-21 | S | D | 1,936 | $330.17 | 119,879 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F10) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $329.540 to $330.510, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 12 | Common | Common Stock | 2026-09-21 | S | D | 2,268 | $331.18 | 117,611 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F11) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $330.705 to $331.520, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 13 | Common | Common Stock | 2026-09-21 | S | D | 6,671 | $332.26 | 110,940 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F12) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $331.730 to $332.725, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 14 | Common | Common Stock | 2026-09-21 | S | D | 5,740 | $333.46 | 105,200 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F13) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $332.750 to $333.740, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 15 | Common | Common Stock | 2026-09-21 | S | D | 25,159 | $334.35 | 80,041 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F14) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $333.750 to $334.745, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 16 | Common | Common Stock | 2026-09-21 | S | D | 25,268 | $335.08 | 54,773 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F15) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $334.750 to $335.740, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 17 | Common | Common Stock | 2026-09-21 | S | D | 9,843 | $336.29 | 44,930 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F16) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $335.765 to $336.750, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 18 | Common | Common Stock | 2026-09-21 | S | D | 15,867 | $337.24 | 29,063 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F17) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $336.780 to $337.750, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 19 | Common | Common Stock | 2026-09-21 | S | D | 7,529 | $338.12 | 21,534 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F18) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $337.780 to $338.720, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 20 | Common | Common Stock | 2026-09-21 | S | D | 2,510 | $338.99 | 19,024 | D | — | — | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F19) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $338.800 to $339.340, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 21 | Derivative | Stock Option (Right to Buy) | 2026-09-18 | M | D | 197,209 | $0.00 | 4,239,446 | D | $8.88 · — to 2029-05-28 | 197,209 Common Stock | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F25) The stock option is fully vested. |
| 22 | Derivative | Stock Option (Right to Buy) | 2026-09-21 | M | D | 102,791 | $0.00 | 4,136,655 | D | $8.88 · — to 2029-05-28 | 102,791 Common Stock | (F1) The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F25) The stock option is fully vested. |